Gestational diabetes & diabetes in pregnancy
Performance of the Dexcom G7 Continuous Glucose Monitoring System in Pregnant Women with Diabetes
Authors' conclusion
The G7 system is accurate and safe during pregnancies complicated by diabetes and does not require confirmatory fingerstick testing.
Study context
- Population
- Pregnant women with T1D, T2D or GDM; 6-h clinic sessions over the 10-day sensor wear96 evaluable · Pregnant women with T1D 59 · T2D 21 · or GDM 25
- Participants
- 105 women
- Comparison
- G7 continuous glucose monitoring (CGM) values vs YSI arterialized venous glucose comparator
- G7n = 96
- Outcome
- Proportion of CGM values in the 70-180 mg/dL range within 15% of comparator glucose values
Performance
As reported in the abstract
CGM values in 70-180 mg/dL range within 15% of comparator values
Pairs with CGM in 70-180 mg/dL range
1739
Within 15% of comparator values
83.2%
Lower bound of 95% CI
79.8%
Secondary outcomes
%20/20 agreement rate, CGM values 40-400 mg/dL
- Pairs
- 2102
- %20/20 agreement rate
- 92.5%
%20/20 agreement rate, comparator values 63-140 mg/dL
- Pairs
- 1659
- %20/20 agreement rate
- 92.3%
%20/20 agreement rate by sensor wear day · days 1, 4 and 7, and 10
- Day 1
- 78.6%
- Days 4 and 7
- 96.3%
- Day 10
- 97.3%
Consensus error grid analysis
- Pairs in clinically acceptable A and B zones
- 99.8%
Safety
- Serious adverse events
- 0
Original publication
Performance of the Dexcom G7 Continuous Glucose Monitoring System in Pregnant Women with Diabetes. Diabetes Technol Ther. Published 1 March 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →